Belimumab promotes negative selection of activated autoreactive B cells in systemic lupus erythematosus patients.
Huang W, Quach TD, Dascalu C, Liu Z, Leung T, Byrne-Steele M, Pan W, Yang Q, Han J, Lesser M, Rothstein TL, Furie R, Mackay M, Aranow C, Davidson A.
Huang W, et al. Among authors: mackay m.
JCI Insight. 2018 Sep 6;3(17):e122525. doi: 10.1172/jci.insight.122525. eCollection 2018 Sep 6.
JCI Insight. 2018.
PMID: 30185675
Free PMC article.